Joëlle Schutten

Chapter 6 150 Magnesium oxide (n=46) Magnesium sulfate (n=46) Magnesium citrate (n=46) 12-wk Mean, mmol/L 140.6 ± 1.8 140.5 ± 1.4 140.1 ± 2.4 Difference vs magnesium citrate 0.3 (-0.3; 0.9) -0.0 (-0.6; 0.5) . . 24-wk Mean, mmol/L 140.4 ± 1.8 140.7 ± 1.8 139.8 ± 1.8 Difference vs magnesium citrate 0.5 (-0.1; 1.0) 0.7 (0.1; 1.2) . . Plasma albumin 2-wk Mean, g/L 44.3 ± 2.0 43.7 ± 2.5 43.2 ± 2.5 Difference vs magnesium citrate 1.2 (0.5 ; 1.9)** 0.8 (-0.0; 1.5) . . 12-wk Mean, g/L 43.8 ± 2.0 43.5 ± 2.1 43.2 ± 2.2 Difference vs magnesium citrate 0.8 (0.0; 1.5) 0.7 (-0.0.; 1.4) . . 24-wk Mean, g/L 43.7 ± 2.3 43.7 ± 2.1 42.5 ± 2.4 Difference vs magnesium citrate 1.5 (0.8; 2.2)** 1.6 (0.9; 2.3)** . . Plasma phosphate 2-wk Mean, mmol/L 0.98 ± 0.15 0.97 ± 0.15 1.02 ± 0.13 Difference vs magnesium citrate -0.03 (-0.06; 0.00) -0.03 (-0.07; 0.00) . . 12-wk Mean, mmol/L 0.99 ± 0.15 1.00 ± 0.14 1.02 ± 0.15 Difference vs magnesium citrate -0.03 (-0.07; 0.00) -0.00 (-0.04; 0.03) . . 24-wk Mean, mmol/L 1.00 ± 0.15 0.99 ± 0.14 1.02 ± 0.14 Difference vs magnesium citrate -0.01 (-0.05; 0.02) -0.01 (-0.05; 0.02) . . Plasma creatinine 2-wk Median 77 (65-85) 70 (66-83) 73 (67-83) Difference vs magnesium citrate -0.0 (-0.0; 0.0) -0.0 (-0; 0.0) . . 12-wk Median 77 (67-88) 72 (65-84) 74 (66-86) Difference vs magnesium citrate 0.0 (-0.0; 0.0) 0.0 (-0.0; 0.0) . . 24-wk Median 76 (63-87) 72 (64-81) 74 (65-83) Difference vs magnesium citrate 0.0 (-0.0; 0.0) 0.0 (-0.0; 0.0) . . Values are mean ± SD or median (interquartile range). Adjusted mean differences (90% CIs) were obtained from linear mixed-effect models with age, sex,baseline value of the outcome of interest, time, intervention, and the interaction time × intervention as fixed effects. * P < 0.05, ** P<0.01 (one-sided P values). Supplemental Table 6. (Continued)

RkJQdWJsaXNoZXIy MTk4NDMw